About Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion
Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion is a rare disease catalogued by Orphanet (ORPHA:363700). It is associated with the NF1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion trials.
Search ClinicalTrials.gov for "Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion" or filter by Orphanet code ORPHA:363700 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion. Updated daily.